Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.59 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.59 |
| ▸ | GAPDH | P04406 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | PPARG | P37231 | 2/20 | 0.47 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.47 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 1/20 | 0.44 |
| ▸ | FPR2 | P25090 | 2/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.44 |
| ▸ | RELA | Q04206 | 1/20 | 0.44 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL868399 | 1.00 | TRPA1 (0.59) | TRPA1DDAH1GAPDHMAPTPPARG | |
| SCHEMBL13952533 | 1.00 | TRPA1 (0.59) | TRPA1DDAH1GAPDHMAPTPPARG | |
| SCHEMBL4104509 | 0.98 | TRPA1 (0.57) | TRPA1DDAH1GAPDHMAPTPPARG | |
| SCHEMBL11313087 | 0.98 | TRPA1 (0.57) | TRPA1DDAH1GAPDHMAPTPPARG | |
| SCHEMBL28600217 | 0.98 | TRPA1 (0.57) | TRPA1DDAH1GAPDHMAPTPPARG | |
| SCHEMBL11313083 | 0.98 | TRPA1 (0.57) | TRPA1DDAH1GAPDHMAPTPPARG | |
| SCHEMBL10899903 | 0.93 | MAPT (0.50) | TRPA1DDAH1GAPDHMAPTPPARG | |
| SCHEMBL17304913 | 0.93 | MAPT (0.50) | TRPA1DDAH1GAPDHMAPTPPARG | |
| Acetic Acid SCHEMBL28658185 | 0.89 | PPARG (0.55) | TRPA1DDAH1GAPDHMAPTPPARG | |
| SCHEMBL10946551 | 0.86 | PPARG (0.53) | TRPA1DDAH1GAPDHMAPTPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10336966-B2 | Fragrance compositions and uses thereof | THE PROCTER & GAMBLE COMPANY (US) | 2019-07-02 | — | — | US | claimed |
| US-9814661-B2 | Fragrance compositions | THE PROCTER & GAMBLE COMPANY (US) | 2017-11-14 | — | — | US | claimed |
| EP-2961374-B1 | FRAGRANCE COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-01-25 | — | — | EP | claimed |
| US-20150164764-A1 | Fragrance Compositions | THE PROCTER & GAMBLE COMPANY | 2015-06-18 | — | — | US | claimed |
| EP-2812316-A2 | AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES | Kao Corporation (JP) | 2014-12-17 | — | — | EP | claimed |
| WO-2013171535-A2 | AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES | KAO CORPORATION (JP) | 2013-11-21 | — | — | WO | claimed |
| EP-4716732-A1 | USE OF ALKYL 4-ALKOXYPENTANOATES AS AROMA CHEMICALS | BASF SE (DE) | 2026-04-01 | — | — | EP | disclosed |
| US-12508218-B2 | Coating compositions | COTY INC. (US) | 2025-12-30 | — | — | US | disclosed |
| EP-3103523-B1 | ABSORBENT ARTICLE COMPRISING FRAGRANCE COMPOSITION | PROCTER & GAMBLE (US) | 2025-10-29 | — | — | EP | disclosed |
| US-20250152487-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | COTY INC. | 2025-05-15 | — | — | US | disclosed |
| US-20250127707-A1 | FRAGRANCE FORMULATION | COTY INC. | 2025-04-24 | — | — | US | disclosed |
| US-20250127694-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | COTY INC. | 2025-04-24 | — | — | US | disclosed |
| US-12178896-B2 | Fragrance compositions and uses thereof | COTY INC. (US) | 2024-12-31 | — | — | US | disclosed |
| US-20150164764-A1 | Fragrance Compositions | THE PROCTER & GAMBLE COMPANY | 2015-06-18 | — | — | US | disclosed |
| WO-2014183883-A1 | CYCLIC ACETALS AND KETALS AND USE THEREOF AS FRAGRANCE | SYMRISE AG (DE) | 2014-11-20 | — | — | WO | disclosed |
| EP-2803666-A1 | Cyclic acetals and ketals and their use as fragrance compounds | Symrise AG (DE) | 2014-11-19 | — | — | EP | disclosed |
| US-20140170194-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | US | disclosed |
| EP-2287158-B1 | Ambergris Odorous Substance based on 9-Methanoazuleno(5,6-d)-1,3-dioxoles | SYMRISE AG (DE) | 2012-11-14 | — | — | EP | disclosed |
| US-20120077722-A1 | AMBERGRIS FRAGRANCE | SYMRISE AG (DE) | 2012-03-29 | — | — | US | disclosed |
| EP-2287158-A1 | Ambergris Odorous Substance based on 9-Methanoazuleno(5,6-d)-1,3-dioxoles | Symrise AG (DE) | 2011-02-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12178896-B2 | Fragrance compositions and uses thereof | FHIT, ALG3, FEM1B | TRPA1 7/4885DDAH1 1114/4885GAPDH 944/4885 |
| US-20250127694-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | TRPA1, TRPV1, NAA40 | TRPA1 1/4885DDAH1 959/4885GAPDH 1552/4885 |
| US-20150164764-A1 | Fragrance Compositions | OGG1, ALKBH5, MYB | TRPA1 13/4885DDAH1 3133/4885GAPDH 1328/4885 |
| US-20250127707-A1 | FRAGRANCE FORMULATION | PUF60, POLM, ADH5 | TRPA1 21/4885DDAH1 2242/4885GAPDH 212/4885 |
| US-20120077722-A1 | AMBERGRIS FRAGRANCE | TRPA1, TAS2R31, TAS2R1 | TRPA1 1/4885DDAH1 4095/4885GAPDH 2616/4885 |
| US-10336966-B2 | Fragrance compositions and uses thereof | CUTA, DPM1, PLIN5 | TRPA1 6/4885DDAH1 309/4885GAPDH 2582/4885 |
| US-12508218-B2 | Coating compositions | TAS2R40, TAS2R20, TAS2R10 | TRPA1 90/4885DDAH1 4348/4885GAPDH 157/4885 |
| US-20250152487-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | FHIT, ALG3, FEM1B | TRPA1 7/4885DDAH1 1114/4885GAPDH 944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.